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Objective: The present study attempts to compare the immunohistochemistry (IHC) of von Willebrand factor (vWf) ,
endothelial cadherin, Caveolin and endothelial Nitric Oxide Synthase (eNOS) in VasoView Endoscopic Vein Harvesting
(EVH) versus traditional Open Vein Harvesting (OVH) techniques for Coronary Artery Bypass Graft (CABG) Surgery
performed in Javad al Aemeh Hospital of Mashhad, Iran in 2013,.
Methods and materials: Forty-seven patients were scheduled for CABG (30 EVH and 17 OVH) among whom
patients with relatively same gender and similar age were selected. Three separate two cm vein samples were
harvested from each patient’s saphenous vein. Each portion was collected from distal, middle and proximal zones
of the saphenous vein. The tissues were deparaffinized, and antigen retrieval was done using EZ-retriever followed
by an immunohistochemistry evaluation with vWf, e-cadherin, Caveolin and eNOS. In addition, demographic
questioner as of Lipid profile, FBS, BMI, and cardiovascular risk factors were collected. Data analyses, including
parametric and nonparametric tests were undertaken using the SPSS 16 software. A P value < 0.05 was regarded as
statistically significant.
Results: The mean age of the EVH and OVH groups were 63.76 ± 9.51 and 63.63 ± 8.31 years respectively with no
significant difference between them (p = 0.989). In addition, there was no great difference between the EVH and
OVH groups in lipid profile, DM, HTN, smoking history, CVA, and valvular dysfunction (P > 0.05). Qualitative report
of vWf, e-cadherin, Caveolin and eNOS reveals no significant difference between the EVH and OVH (P > 0.05).
Conclusion: This study indicates that VasoView EVH technique causes no endothelial damage in comparison with
OVH. This study could be a molecular confirmation for the innocuous of EVH technique.
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Many people around the world suffer from coronary ar-
tery disease (CAD) that causes an enormous morbidity
and mortality. In order to rescue individuals with this dis-
ease there is the major and best operation/cardiac surgery
known as coronary artery bypass grafting (CABG) [1].
This specified surgery is performed on individuals with
each of followed diseases: 1) left main coronary artery dis-
ease, 2) 3-vessel disease, 3) 3-vessel disease in diabetics, 4)* Correspondence: pouya_dg@yahoo.com
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unless otherwise stated.severely depressed heart function, and 5) heart conditions
in addition to CAD e.g. replacement of valves or recon-
struction of the heart muscle [1].
More than 300,000 CABG operations are performed in
the North America annually [2]. Furthermore, it has been
reported that over 10,000 patients require CABG every
year in Iran [3]. However, complication rates, morbidity
and mortality after CABG surgery are still expected to en-
hance despite advances in this field of the surgery to over-
come CAD and rescue the patients [4], so surgeons should
reduce the other risk factors of mortality and morbidity of
CABG such as wound complications of saphenous vein.l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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creases the wound complications related with open tech-
niques [5]. In order to decrease the considerable morbidity
and wound complications associated with the extensive in-
cisions made in traditional approach to vein harvest, min-
imally invasive techniques such as EVH is recommended
[6]. Also using minimally invasive methods could reduce
intra-operative complications [7,8]. EVH uses CO2 and an
endoscope to harvest the saphenous vein by a single tiny
incision [9].
In traditional methods of greater saphenous vein har-
vesting, large incisions must be taken; however, local pain
in leg, dysmobility, wound infection, wound bleeding, pro-
longed hospital stay, and insufficient cosmetic results
could happen [10,11].
A meta-analysis showed that EVH is safe and reduced
rates of wound complications; leg wound infection, wound
hematoma, and post operational pain, compared to trad-
itional open techniques [6]. This research team in their
previous study found EVH has fewer postoperative wound
complications and less postoperative pain in comparison
with OVH [8].
Allen KB et al. reported that “five-year follow-up of a
prospective randomized clinical trial (RCT) display that
use of EVH does not influence event-free survival” [5].
Some other scientists believe that EVH is independently
associated with vein-graft failure [12]. Disruption of the
endothelium by any instruments may cause the vein-graft
failure so some heart surgeons still have doubts about
EVH and they believe that it might cause damage to sa-
phenous vein endothelium tissue [13]. Endothelial Nitric
Oxide (eNOS), endothelial Caveolin (e-Caveolin), von
Willebrand factor (vWf), and cadherin can evaluate endo-
thelial function and damages [14]. Endothelial damage can
be shown by displaced or decreased expression of eNOS
and Caveolin [14]. vWF can demonstrate endothelial cell
damage [15]. Serine/threonine protein kinase Akt can acti-
vate eNOS and endothelial dysfunction is due to the inad-
equate NO synthesis [16].
Although, vascular endothelial (VE)-cadherin is more
specific to vascular endothelium but expression of this ad-
hesion molecule might be an index for permeability and
leukocyte extravasations. Therefore, we decided to evalu-
ate e-cadherin [17].
The present study attempts to compare the immuno-
histochemistry of vWf, e-cadherin, Caveolin and eNOS
in VasoView endoscopic saphenous vein versus traditional
open vein harvesting techniques for CABG Surgery per-
formed in Javad al Aemeh Hospital of Mashhad, Iran
in 2013.
Methods
From June 2013 to October 2013, 47 patients underwent
CABG in Mashhad, Northeast of Iran. EVH performedon 30 patients and 17 had OVH. According to a preivouse
research [13] and Daniel formula (Daniel 1999, Z value
was 1.96, Expected proportion was 0.01, and Precision (d)
was 0.0025) we used to determine the sample size of this
study, so we needed 15.84 (≈16) cases in each group. Then
we selected 17 controls in OVH and increased EVH group
up to 30 cases.
This is a prospective cohort study, and demographic in-
formation (age, gender, educational level, marital status,
income, and occupation), family history of CAD, smoking
habits, FBS level and serum lipid profiles were almost
similar in all patients.
All 47 patients had a same chance to be either in EVH
or OVH group, they were numbered blindly, and then 17
numbers were selected from random number table for
OVH and other 30 numbers were selected for EVH group.
As a primary choice for anastomosis, mammary arteries
were used for the first vessel grafting in all 47 patients,
and saphenous veins were used for the remaining number
of anastomoses needed.
Three separate two cm vein samples were harvested
from each of patient’s saphenous vein (distal, medial, prox-
imal vein) for each EVH and OVH techniques, immedi-
ately after the harvesting.
Endoscopic operative technique
Endoscopic dissection and excision of the saphenous vein
has the advantage of requiring smaller skin incision, which
heals better.
Our EVH method is based on the CO2 technique using
a sealed and constant method of CO2 insufflations (Vaso-
View HemoPro 2; Maquet©).
A small incision is made 1.5-2.5 cm below/above the
knee to build the entrance of the probe, which then con-
tinues its path toward the groin region. For dividing the
branches, we used a bipolar cauterizer and by the use of a
Scissor, a punctured incision was made to clamp, ligate
and divide the vein. Ligation for small-size side branches
was performed by clips whereas large-size branches and
sites of basal disruption ligated with 7.0 monofilament
prolene suture (this surgical team method), in addition to
the application of clips for a greater blockage of the
branches after harvesting the vein (Figure 1).Open operative technique
At first, the leg was abducted and rotated laterally by pla-
cing a roll under knee. After a long incision was made over
the saphenous vein, side branches were ligated/clipped.
The vein was then removed and prepared after the
closure of the incision site in layers with absorbable
suture and the leg wound was covered with cotton
gauze dressing, in addition to applying an elastic ace to
the entire leg (Figure 1).
Figure 1 EVH and OVH procedure (EVH at right and OVH at left).
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Three micrometer thick tissue sections were placed on
slides covered by Poly-L-Lysin, deparaffinized by xylol,
and was dehydrated by graded alcohols for 10 minutes.
Endogenous peroxidase activity was inhibited in H2O2-
methanol solution. The de-paraffinized slides were rinsed
with PBS and encountered with non-immune serum 10%
for 10 minutes. Then cuts were incubated in a humidified
chamber with an appropriate dilution of antibody (50 to
100 microliter) for 30–60 min at room temperature. Slides
were washed in PBS for 5 min (Three replacements) and
were incubated in a solution containing 3, 3 with 3 -
amino −9 - ethyl. Counterstain was performed with Gill’s
triple-strength hematoxylin. All these experimental proce-
dures were performed under the instruction and protocols
of Leica Biosystem (Novocastra) Corporation which is avail-
able in every immunohistochemistry kit. Immunohisto-
chemistry staining was done for vWf, e-cadherin, Caveolin
and eNOS. Negative staining reported by “-”, weakly posi-
tive staining reported by “, positive samples were reported
by “ + ”, and finally strongly positive samples were reported
by “++”. Single expert pathologist in IHC staining examined
all samples (Figure 2).
Statistical analysis
Statistical analysis used was the Statistical Package for
Social Sciences version 16(SPSS Inc., Champaign, IL, USA).
The Kolmogorov-Smirnov test was used to assess normal-
ity. Descriptive statistics (frequency, mean, and standardFigure 2 eNOS, vWF, e-cadherin, and ccaveolin in EVH and OVH imm
by a same expert pathologist, as micrographs showed same staining intendeviation) were determined for all variables. Values are
reported as mean ± SD for normally distributed vari-
ables (or Median and Interquartile range (IQR) for not
normal distribute variables). Baseline demographics and
clinical characteristics were compared between groups
using t-student test, chi-square test, Friedman test, and/or
Fisher exact test as appropriate. A p value < 0.05 was con-
sidered as significant.
Results
Mean age has no significant difference between EVH
and OVH 63.76 ± 9.51 and 63.63 ± 8.31 respectively (P =
0.961). In addition, there is no noticeable difference be-
tween groups in gender, smoking, hypertension, hyper-
lipidemia, CVA history, BMI, and family history of CAD
(P > 0.05) (Table 1).
Most of the patients were referred to our center due
to three-vessel coronary disease (Table 1).
BUN, Cr, FBS, total cholesterol, LDL-C, HDL-C, and
triglyceride had no significant difference between EVH
and OVH group (P > 0.05) (Table 1).
Multivariate regression analysis demonstrated no influ-
ence of basic characteristics variable on IHC outcome.
According to Table 2, eNOS, E-cadherin, Caveolin, and
vWF immunohistochemistry staining in distal, medial and
proximal zones of vein samples in both groups had no sig-
nificant statistical difference (P > 0.05) (Table 2) (Figure 2).
Hospital follow-ups were performed including echo-
cardiography, CKB-MB and Troponin cardiac enzymes.unohistochemistry slides. Qualitative assessing of slides were done
sity in intercellular and intracellular space.
Table 1 Characteristics data from all subjects in each
group
Variable EVH (n = 30) OVH (n = 17) P value
Age (year) 63.76 ± 9.51 63.63 ± 8.31 0.961
Sex
Male 23(76.7) 11(64.7) 0.378
Female 7(23.3) 6(35.3)
Smoking
Yes 9(32.1) 7(41.2) 0.539
No 19(67.9) 10(58.8)
Diabetes mellitus
Yes 14(51.9) 2(11.8) 0.007
No 13(48.1) 15(88.2)
Hypertension history
Positive 16(59.3) 11(64.7) 0.718
Negative 11(40.7) 6(35.3)
Hyperlipidemia history
Positive 15(53.6) 8(47.1) 0.672
Negative 13(46.4) 9(52.9)
CVA (stroke) history
Positive 0(0.0) 0(0.0) -
Negative 28(100) 17(100)
Family history of CAD
Positive 8(26.6) 4(23.5) 0.931
Negative 22(74.4) 13(76.5)
Valvular disease comorbidity
Positive 2(7.1) 2(11.8) 0.597
Negative 26(92.9) 15(88.2)
CABG reason
2VD 1(3.6) 2(11.8) 0.285
3VD 27(96.4) 15(88.2)
BMI 27.50 ± 4.93 26.00 ± 3.86 0.291
BUN 35.78 ± 20.41 29.85 ± 14.67 0.346
Creatinine 0.99 ± 0.27 1.09 ± 0.25 0.240
FBS (mg/dl) 136.0 ± 55.83 111.81 ± 36.1 0.128
TC (mg/dl) 158.11 ± 45.68 207 ± 122.73 0.063
LDL-C (mg/dl) 69.77 ± 36.50 94.07 ± 40.21 0.058
HDL-C (mg/dl) 51.25 ± 13.56 50.85 ± 6.13 0.917
TG (mg/dl) (median(IQR)) 165(72) 175(85) 0.294
Date are shown as Number (percent), or mean ± SD, or (median (IQR)).
CVA: cerebrovascular accident, CABG: Coronary artery bypasses surgery, BMI:
Body Mass Index, BUN: blood urea nitrogen, FBS: Fasting blood sugar, TC: total
cholesterol, LDL-C: Low density lipoprotein cholesterol, HDL-C: High-density
lipoprotein, TG: triacylglyceride, CAD: Coronary artery disease, 2VD: two-vessel
coronary artery disease, 3VD: three-vessel coronary artery disease.
Table 2 Immunohistochemistry results from all subjects
in each group
Variable EVH OVH P value


























































Date are shown as Number (percent).
NOS: nitric oxide synthase, vWF: Von Willebrand factor.
P*: P value of Friedman test for comparing distal, medial, and proximal sample
within group of OVH.
P**: P value of Friedman test for comparing distal, medial, and proximal
sample within group of EVH.
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in one patient who underwent OVH. This rise was
managed to the normal range in the period of hospitalstay and no wall motion abnormality or EF changing
appeared in echocardiography.
Finally, we have compared three samples taken from
each person in both groups, which were analyzed by
Friedman test, and we found no significant difference
between IHC results in same patient in different parts
of vein (P > 0.05) (Table 2). In simple H&E histological
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ference between groups.
Discussion and conclusion
Chronic wounds or post operation complicated wounds
are associated with increased morbidity and mortality
and pose a serious economic burden on the health-care
system. It has been estimated that nearly $25 billion is
spent annually in the United States to treat ulcers [18].
These chronic and non-healing wounds are the ones in
which the healing progress is less than (20-40% reduction
in the area) after 2–4 weeks of appropriate approach and
treatment [19].
Traditional greater saphenous vein harvesting may in-
crease the post operation wound complications [20].
These wounds and their complications can influence
the patient’s physical activity and may make limitations
for patients, so it is very harmful in post CABG rehabili-
tation therapy [21]. Surgeons’ fatigue before they reach
to the main part of the operation procedure is crucial;
however, a great amount of time is gained for skin clos-
ure in OVH technique [22] whereas, EVH is performed
at a satisfactory shorter time [23]. Considering all of these
points, minimal invasive vein harvesting is noticeable.
Some surgeons and scientists believe that EVH may
destroy greater saphenous vein tissue and it could be
harmful for bypass grafting [12]. In this study, we aimed
to compare the IHC tissue staining result between EVH
and OVH greater saphenous vein.
According to our results, there were no significant dif-
ferences between same site samples in EVH and OVH
between patients and no noticeable difference in distal,
medial and proximal sites within a patient sample was
detected in eNOS, E-cadherin, Caveolin, and vWF.
Bader E. Hussain et al. in 2011 reported that EVH preserve
the structural and functional viability of greater saphenous
vein [13]. They found that western blots, immunofluores-
cent, multiphoton imaging had no difference for caveolin 1,
eNOS, Cadherin, and vWf between EVH and OVH [13].
There were no changes in caveolin and eNOS in the
vein endothelial in EVH technique in this study. These re-
sults are very important for evidence-based decision and
in molecular view, there are no structural and cellular via-
bility harm effect found in EVH compared with OVH.
Iamar M. Al Saggaf et al. found statistically insignificant
difference between EVH and OVH by scanning electron
microscopy (SEM) assay [24]. In other histological studies,
there were minimal and negligible changes between EVH
and OVH in light and electronically microcopy [25-28].Limitations
Matching patients with similar criteria as of DM was
our limitation.Ethical issue
The study was conducted in accordance with the princi-
ples of Declaration of Helsinki 1996 version and Good
Clinical Practice standards. All subjects signed informed-
consent forms.
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